Medpace Holdings (NASDAQ: MEDP) reported Q2 Adj. EPS of $0.61, $0.19 better than the analyst estimate of $0.42. Revenue for the quarter came in at $170.1 million versus the consensus estimate of $154.86 million.

GUIDANCE:

Medpace Holdings sees FY2018 Adj. EPS of $2.51-$2.62, versus the consensus of $1.91.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.